Related Experiment Video
Updated: Sep 21, 2026

Chromosome Preparation From Cultured Cells
Published on: January 28, 2014
Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant
1Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Abstract:
Recent studies of several drug-resistant Chinese hamster cell lines suggested that a breakage-fusion-bridge mechanism is frequently involved in the amplification of drug resistance genes. These observations underscore the importance of chromosome breakage in the initiation of DNA amplification in mammalian cells. However, the mechanism of this breakage is unknown. Here, we propose that the site of chromosome breakage consistent with the initial event of P-glycoprotein (P-gp) gene amplification via the breakage-fusion-bridge cycle in three independently established multidrug-resistant CHO cells was located at 1q31. This site is a major chromosome fragile site that can be induced by methotrexate and aphidicolin treatments. Pretreatments of CHO cells with methotrexate or aphidicolin enhanced the frequencies of resistance to vinca alkaloid and amplification of the P-gp gene. These observations suggest that chromosome fragile sites play a pivotal role in DNA amplification in mammalian cells. Our data are also consistent with the hypothesis that gene amplification can be initiated by stress-induced chromosome breakage that is independent of modes of action of cytotoxic agents. Drug-resistant variants may arise by their growth advantage due to overproduction of cellular target molecules via gene amplification.
Insights
Chromosome breakage at fragile sites initiates DNA amplification, leading to drug resistance. Methotrexate and aphidicolin treatments enhance this process, suggesting fragile sites are key in gene amplification.
Area of Science:
- Genetics
- Cell Biology
- Molecular Biology
Background:
- Drug resistance in mammalian cells often involves gene amplification.
- The breakage-fusion-bridge (BFB) mechanism is implicated in gene amplification.
- The precise mechanism initiating chromosome breakage in BFB is not fully understood.
Purpose of the Study:
- To identify the specific chromosomal site of breakage involved in P-glycoprotein (P-gp) gene amplification.
- To investigate the role of chromosome fragile sites in initiating DNA amplification.
- To explore the influence of specific chemical treatments on gene amplification frequency.
Main Methods:
- Analysis of multidrug-resistant Chinese hamster ovary (CHO) cell lines.
- Induction of chromosome fragile sites using methotrexate and aphidicolin.
- Quantification of P-gp gene amplification and drug resistance.
Main Results:
- Chromosome breakage associated with P-gp gene amplification via BFB was localized to 1q31 in CHO cells.
- Site 1q31 is a known fragile site inducible by methotrexate and aphidicolin.
- Pretreatment with these agents increased vinca alkaloid resistance and P-gp gene amplification frequency.
Conclusions:
- Chromosome fragile sites are pivotal in initiating DNA amplification in mammalian cells.
- Stress-induced chromosome breakage, independent of cytotoxic agent action, can initiate gene amplification.
- Gene amplification provides a growth advantage to drug-resistant variants through target molecule overproduction.
Related Concept Videos
Fixing Double-strand Breaks
DNA Damage can Stall the Cell Cycle
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

